Biostem US Corporation President Announces Study Results on Stem Cell Hair Loss Treatment


CLEARWATER, FL, Nov 16, 2011 (MARKETWIRE via COMTEX) — Biostem US Corporation (otcqb:BOSM) (pinksheets:BOSM) (Biostem, the Company), a regenerative medicine company, announced completion of a two year study on treating Alopecia Areata, thought to be an autoimmune disease, which causes sudden hair loss.

On October 28th, John Satino, President of Biostem, announced results of a two year consumer study conducted at a Biostem affiliate clinic in Florida at The international Stem Cell & Cicatrical Alopecia Symposium. The Symposium was held in Bethesda, Maryland and sponsored by Case Western Reserve School of Medicine and The National Institutes of Health Rare Disease Research Office.

The study involved 700 patients, with results showing renewed hair growth in 80% of the participants. The treatment, developed by Biostem, includes a combination of the patients own blood, utilization of growth factors, laser treatments for bio-photo stimulation, and a nutraceutical designed to stimulate hair follicle growth. This unique combination of treatments is known as “The Biostem Method(TM).”

“We are very encouraged by these positive results and our ability to help the large number of men and women experiencing hair loss, said Satino. Biostem will continue to improve the process, and expand its availability to licensed medical practitioners through a license and affiliate program to be available in the next few months.”

A central focus of the Biostem Method(TM) uses the patients’ own blood which is processed to become Platelet Rich Plasma (PRP), a concentration of the body’s own cells which contain healing and growth factors. PRP has come to recent national attention when used to treat soft tissue repair in notable athletes such as Tiger Woods and Terrell Owens.

For treatments that work without any side effect read:

Do you have Hair Loss Problems, read our Hair Loss Help

Please like & share:
no comment

Biostim Blocking DHT to Stop Male Hair Loss



Science has long known that the majority of male pattern baldness is caused by a combination of genetics and the effects of DHT. DHT, also known by its chemical name Dihydrotestosterone, is a byproduct of our own male hormone testosterone. A naturally-occurring enzyme called 5 alpha-reductase (5AR) binds with testosterone and mutates it into DHT. DHT is a virulent hormonal byproduct that attacks genetically susceptible hair follicles, resulting in hair loss in men. Since the mechanism by which DHT acts on hair is fairly well understood, it would seem that blocking DHT would be a straightforward solution. Unfortunately, blocking DHT is only one step in the battle against male hair loss.
In order to truly “block” DHT from causing hair loss, one of two general approaches to DHT-blocking must be taken.

1. Blocking DHT from attaching to androgen receptors in the hair follicle to prevent it from killing off the hair follicle.
2. Block the transformation of testosterone into DHT in the first place.

Many prescription hair loss medications focus on only the first option, blocking the receptor cells of the hair follicle so that DHT cannot bind to the hair follicle. While this can reduce the rate of hair loss, a more effective methodology would include blocking the chemical process that changes testosterone into DHT, without reducing or effecting testosterone levels, as some medications do. A dual approach to blocking DHT tends to be more effective than hair loss solutions that only focus on one component of the DHT problem.
Biostim is an all-natural supplement for male hair loss a topical lotion with a nutritional supplement to stopping hair loss, without the usage of medication. For more information about the Biostim DHT-blocking system

Do you have Hair Loss Problems, read our Hair Loss Help

Please like & share:
1 comment





A combination of naturally occurring 5-reductase inhibitors with added multivitamin complex for the stimulation of hair follicles suppressed by the action of Androgens in cases of androgenic alopecia.



Aqua, Sabal Serrulata ext, Propylene Glycol, PEG-35 Castor Oil. Polysorbate 20, Aesculus Hipposastanum etx, Retinyl Palmitate, Tocopherol, PABA, Inositol, Calcium Pantothenate, Linoleic Acid, Biotin, Urea, Allantoin, Phenoxyethanol, Methyl Paraben, Butyl Paraben, Ethyl Paraben, Propyl Paraben, Isobutyl Paraben.

Mode of Action

5-reductase inhibitors act as anti-androgens, reducing the levels of di-hydroxy testosterone (DHT), decreasing the levels of androgen activity at the target site.  The consequent reduced levels of DHT stabilise or reduce the level of atrophy of the hair follicle and shaft in the genetically determined areas in the treatment of androgenic alopecia.  The hair growth period (anagen) is prolonged and promotes increased hair growth and density.

Clinical Trials

Clinical trials of the natural ingredients have established anti-androgen activity and the ability to suppress di-hydroxy testosterone (DHT) formation, beneficial in cases of androgenic alopecia.  The increased dermal papilla activity increases hair cell production and proliferation, increases the number of hairs in the anagen phase and increases the A/T (anagen/telogen ration). 

In order to treat hair loss effectively we would recommend that you have a diagnosis made as soon as possible by one of our experienced Westminster Trichologists. Stress can be an aggravator in almost all cases of hair loss and an accurate diagnosis will always, at the very least, take some of the stress away from you.

Do you have Hair Loss Problems, read our Hair Loss Help

Please like & share:
no comment